Hospital Vall d'Hebron

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
2	Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors	Active, not recruiting	Active	LOXO-101	NCT02576431
1	Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer	Terminated	Closed	PF-052112384 + PD-0325901 OR PF-052112384 + Irinotecan	NCT01347866
1	Study of the Safety and Pharmacokinetics of XL147 in Adults With Solid Tumors	Ongoing, but not recruiting	Closed	XL147	NCT00486135
1	Study of the Safety and Pharmacokinetics of XL765 in Adults With Solid Tumors	Ongoing, but not recruiting	Closed	XL765	NCT00485719
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722
			Active